BENJAMIN SCOTT: Open Payments
NPI 1144717000 · GREENCASTLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$444 in 24 payments from 10 companies in 2025. Trend: 2023 $436 · 2024 $584 · 2025 $444
Food & beverage: $444
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $152 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $79 |
| Corium, LLC | 3 | $52 |
| Lilly USA, LLC | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| COLOPLAST CORP | 1 | $19 |
| Viatris Specialty LLC | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: VRAYLAR, CAPLYTA, Azstarys, JARDIANCE, FARXIGA, Biatain Ag Non-Adhesive, MOUNJARO, UBRELVY.
Industry payments across IN — which companies pay providers there.
